We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Trevena Inc | NASDAQ:TRVN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.039 | 10.16% | 0.4228 | 0.4028 | 0.4467 | 0.41 | 0.38 | 0.3861 | 77,020 | 00:58:26 |
The Company will host a conference call and webcast with the investment community on Wednesday, August 7th at 8:00 a.m. Eastern Time featuring remarks by Carrie Bourdow, President and CEO, Mark Demitrack, SVP and Chief Medical Officer, and Barry Shin, SVP and Chief Financial Officer.
What: | Trevena Second Quarter 2019 Results Conference Call |
Date: | Wednesday, August 7, 2019 |
Time: | 8:00 a.m. ET |
Live Call: | Toll-Free: (855) 465-0180International: (484) 756-4313 |
Webcast: | investors.trevena.com |
Replay: | Toll-Free: (855) 859-2056International: (404) 537-3406Conference ID: 3799758(Available approximately one hour after the completion of the live call until 11:59 p.m. ET on August 14, 2019) |
About TrevenaTrevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions. The Company has four novel and differentiated investigational drug candidates, including IV oliceridine for the management of moderate to severe acute pain in hospitals, TRV250 for the acute treatment of migraine, and TRV734 for maintenance treatment of opioid use disorder. The Company has also identified TRV045, a novel S1P receptor modulator that may offer a new, non-opioid approach to managing chronic pain.
For more information, please contact:
Investor Contact:Valter Pinto / Allison SossKCSA Strategic CommunicationsPhone: 212-896-1254 / 212-896-1267Email: IR@trevena.com
Company Contact:Bob Yoder, SVP and Chief Business OfficerTrevena, Inc.Phone: 610-354-8840
1 Year Trevena Chart |
1 Month Trevena Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions